Big Money Sentiment decreased to 0.94 in Q3 2018. It has change of 0.78, from 2018Q2’s 1.72. The ratio dived due to Prestige Consumer Healthcare Inc. positioning: 21 sold and 73 reduced. 27 funds took holdings and 61 increased holdings. Investors holded 61.54 million in 2018Q2 but now own 62.29 million shares or 1.22% more.
Champlain Invest Prns Ltd Llc accumulated 2.08M shs or 0.7% of the stock. Pnc Fincl Grp Inc invested in 0% or 5,168 shs. Citadel Advsrs Llc stated it has 0.01% of its capital in Prestige Consumer Healthcare Inc. (NYSE:PBH). Oppenheimer Asset Management accumulated 9,510 shs. Northwestern Mutual Wealth holds 0% in Prestige Consumer Healthcare Inc. (NYSE:PBH) or 583 shs. 78,730 are held by Alliancebernstein L P. Delta Asset Management Ltd Liability Corporation Tn invested 0% in Prestige Consumer Healthcare Inc. (NYSE:PBH). Metropolitan Life New York owns 17,239 shs. State Of Wisconsin Inv Board accumulated 16,100 shs. Ing Groep Nv has 0.01% invested in Prestige Consumer Healthcare Inc. (NYSE:PBH) for 7,909 shs. Great West Life Assurance Can stated it has 29,049 shs. Acadian Asset Ltd Liability Corporation owns 0.16% invested in Prestige Consumer Healthcare Inc. (NYSE:PBH) for 1.00M shs. Dimensional Fund Advsr L P invested 0.05% of its capital in Prestige Consumer Healthcare Inc. (NYSE:PBH). Grp Inc holds 0.02% or 138,746 shs. Oregon Pub Employees Retirement Fund accumulated 20,956 shs.
Prestige Consumer Healthcare Inc (NYSE:PBH) had a decrease of its shorted shares by 4.43%. FINRA published in March PBH’s total 9.57 million shorted shares. The 10.01M previous shares are down with 4.43%. With Average volume 585,100, PBH’s previous position will take 16 days to restore. Float short on Prestige Consumer Healthcare Inc is 19.68%.
The stock increased 0.07% or $0.02 during the last trading session, reaching $29.28.Prestige Consumer Healthcare Inc. has volume of 398,406 shares. Since March 2, 2018 PBH has declined 26.53% and is downtrending. PBH underperformed the S&P 500 by 26.53%.
Prestige Brands Holdings, Inc., through its subsidiaries, markets, sells, makes, and distributes over-the-counter healthcare and household cleaning products in North America, Australia, and internationally.The firm is valued at $1.52 billion. It operates through North American OTC Healthcare, International OTC Healthcare, and Household Cleaning divisions.The P/E ratio is 24.24. The companyÂ’s OTC healthcare products include Chloraseptic sore throat treatments and mouth pain products, Clear Eyes eye care products, Compound W wart removers, Dramamine Non-Drowsy naturals, Efferdent denture cleansers, Luden's throat drops, BC and Goody's analgesic powders, Beano for gas prevention, Debrox for ear wax removal, and Gaviscon for upset stomach remedies.
For more Prestige Consumer Healthcare Inc. (NYSE:PBH) news posted recently go to: Benzinga.com, Globenewswire.com, Globenewswire.com, Seekingalpha.com or Globenewswire.com. The titles are as follows: “Earnings Scheduled For February 7, 2019 – Benzinga” posted on February 07, 2019, “Prestige Consumer Healthcare Inc. Reports Fiscal 2019 Third Quarter Results – GlobeNewswire” on February 07, 2019, “New Research: Key Drivers of Growth for FireEye, DXC Technology, Cigna, Ryder System, Prestige Consumer Healthcare, and Martin Marietta Materials — Factors of Influence, Major Initiatives and Sustained Production – GlobeNewswire” with a publish date: February 20, 2019, “Prestige Brands (PBH) Presents At 2019 ICR Conference – Slideshow – Seeking Alpha” and the last “Prestige Consumer Healthcare Inc. Updates Third Quarter and Fiscal 2019 Guidance; Announces Participation in the 21st Annual ICR Conference – GlobeNewswire” with publication date: January 14, 2019.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.